OPTIMAPHARM Trademark

Trademark Overview


On Friday, February 7, 2020, a trademark application was filed for OPTIMAPHARM with the United States Patent and Trademark Office. The USPTO has given the OPTIMAPHARM trademark a serial number of 79285462. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, August 11, 2021. This trademark is owned by OPTIMAPHARM d.d.. The OPTIMAPHARM trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Electronic publishing services, namely, publication of text and graphic works of others on recorded media and on-line featuring medical research publication of books; publication of texts, other than publicity texts; providing online publications in the nature of electronic books and journals in the field of diseases and medical and pharmaceutical research providing online electronic publications, not downloadable in the nature of diseases and medical and pharmaceutical in the field of diseases and medical and pharmaceutical research; news reporters services

Corporate communications services, namely, providing consultation regarding public relations communication strategies to businesses; organization of exhibitions for commercial or advertising purposes; organization of trade fairs; distribution of samples, advertising by mail order, rental of advertising time on communication media; wholesale store services for pharmaceutical, veterinary and medical preparations and supplies, retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; drawing up of statements of accounts, namely, preparation of financial statements; business auditing, compilation of information into computer databases, systemization of information into computer databases; psychological testing for the selection of personnel; human resources consultancy, personnel recruitment; billing; updating and maintenance of data in computer databases; photocopying services; appointment scheduling services [office functions...

Technical writing; data security consultancy; research and development of new products for others; technical research in the field of pharmaceutical studies, conducting clinical trials for others [conducting], research related to pharmaceuticals, research on the subject of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the pharmaceutical and biotechnology fields, clinical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders consultancy relating to research and development in the field of therapeutics,...
optimapharm

General Information


Serial Number79285462
Word MarkOPTIMAPHARM
Filing DateFriday, February 7, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, August 11, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesElectronic publishing services, namely, publication of text and graphic works of others on recorded media and on-line featuring medical research publication of books; publication of texts, other than publicity texts; providing online publications in the nature of electronic books and journals in the field of diseases and medical and pharmaceutical research providing online electronic publications, not downloadable in the nature of diseases and medical and pharmaceutical in the field of diseases and medical and pharmaceutical research; news reporters services
Description of MarkThe mark consists of the wording "OPTIMAPHARM" in dark blue next to a design of four circles. The circles are dark blue, dark rose, blue, and violet. The remaining white represents background or transparency only and is not claimed as a feature of the mark.
Pseudo MarkOPTIMA PHARM
Indication of Colors claimedThe color(s) dark blue, blue, violet and dark rose is/are claimed as a feature of the mark.
Goods and ServicesCorporate communications services, namely, providing consultation regarding public relations communication strategies to businesses; organization of exhibitions for commercial or advertising purposes; organization of trade fairs; distribution of samples, advertising by mail order, rental of advertising time on communication media; wholesale store services for pharmaceutical, veterinary and medical preparations and supplies, retail store and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; drawing up of statements of accounts, namely, preparation of financial statements; business auditing, compilation of information into computer databases, systemization of information into computer databases; psychological testing for the selection of personnel; human resources consultancy, personnel recruitment; billing; updating and maintenance of data in computer databases; photocopying services; appointment scheduling services [office functions], business management consultancy, business management and organization consultancy, business organization consultancy, professional business consultancy, advisory services for business management; rental of office machines and equipment
Goods and ServicesTechnical writing; data security consultancy; research and development of new products for others; technical research in the field of pharmaceutical studies, conducting clinical trials for others [conducting], research related to pharmaceuticals, research on the subject of pharmaceuticals, research and development for the pharmaceutical industry, research and development in the pharmaceutical and biotechnology fields, clinical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders consultancy relating to research and development in the field of therapeutics, consultancy relating to laboratory testing, consultancy in the field of pharmaceutical research, calibration services relating to medical apparatus, research and development of vaccines and medicines, pharmaceutical products research, testing of pharmaceuticals, consultancy relating to pharmacology, pharmaceutical drug development services, biological research, clinical and medical research in the field of hematology, oncology, cardiovascular diseases and disorders, metabolic disorders, diabetes, endocrinology, gastro-intestinal diseases and disorders, hepatic and biliary diseases and disorders, hiv and related conditions, immunology, infectious diseases, musculoskeletal diseases and disorders, neurology, psychiatry, reproduction, respiratory diseases and disorders, sensory organs, dermatology, surgery and surgical procedures, urinary tract diseases and disorders, medical research, conducting early evaluations in the field of new pharmaceuticals, pharmaceutical product evaluation, conducting clinical trials for others for pharmaceutical products, conducting clinical trials for others in the field of cardiovascular disease, conducting clinical trials for others, provision of information and data relating to medical and veterinary research and development, providing information about the results of clinical trials for pharmaceutical products, providing medical and scientific research information in the field of pharmaceuticals and clinical trials, providing scientific information in the field of medical disorders and their treatment, development of pharmaceutical preparations and medicines, pharmaceutical products development

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOPTIMAPHARM d.d.
Party Type10 - Original Applicant
Legal Entity Type09 - Joint Stock Company
AddressHR

Trademark Events


Event DateEvent Description
Monday, August 29, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, August 11, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 11, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 8, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, October 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 20, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, August 11, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, August 11, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 25, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, January 25, 2021FINAL REFUSAL E-MAILED
Monday, January 25, 2021FINAL REFUSAL WRITTEN
Tuesday, December 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, July 18, 2020REFUSAL PROCESSED BY IB
Tuesday, June 30, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 30, 2020REFUSAL PROCESSED BY MPU
Thursday, May 28, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 27, 2020NON-FINAL ACTION WRITTEN
Tuesday, May 19, 2020APPLICATION FILING RECEIPT MAILED
Friday, May 15, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 14, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB